PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,819,000 | +2254.0% | 685,687 | +938.6% | 0.01% | +1000.0% |
| Q3 2020 | $672,000 | -64.7% | 66,022 | -48.3% | 0.00% | -66.7% |
| Q2 2020 | $1,904,000 | +61.5% | 127,811 | +32.2% | 0.00% | 0.0% |
| Q1 2020 | $1,179,000 | +90.8% | 96,687 | +92.1% | 0.00% | +200.0% |
| Q3 2019 | $618,000 | -74.0% | 50,338 | -72.1% | 0.00% | -75.0% |
| Q2 2019 | $2,379,000 | – | 180,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 13,822,463 | $318,884,000 | 2.79% |
| HARVEST MANAGEMENT LLC | 70,000 | $1,615,000 | 1.32% |
| HARVEST MANAGEMENT LLC | 70,000 | $1,615,000 | 1.32% |
| EQUITEC PROPRIETARY MARKETS, LLC | 215,300 | $4,967,000 | 1.30% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 206,867 | $4,773,000 | 1.00% |
| Boxer Capital, LLC | 1,123,105 | $25,910,000 | 0.83% |
| TIG Advisors, LLC | 709,282 | $16,363,000 | 0.82% |
| Newtyn Management, LLC | 153,617 | $3,544,000 | 0.82% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 857,705 | $19,787,000 | 0.81% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 205,800 | $4,748,000 | 0.74% |